Tag Archives: Safety

ADA: Novo Nordisk’s oral semaglutide posts another heart safety win

SAN FRANCISCO—Novo Nordisk may have already submitted its approval application for its oral GLP-1 drug semaglutide, but the deluge of positive data hasn’t stopped. Tuesday at the American Diabetes Association annual meeting, the Danish drugmaker rolled out cardiovascular outcomes results showing that the its wannabe blockbuster didn’t hurt cardiovascular safety in high-risk Type 2 diabetes… Read More »

In Brief: Increased Use of Cannabis During Pregnancy, But Little Data on Reproductive Safety

Despite decreasing rates of alcohol and tobacco use during pregnancy, the use of cannabis use during pregnancy is on the rise.  According to data collected from the National Survey on Drug Use and Health, the use of cannabis in pregnant women aged 18 to 44 years rose from 2.37% in 2002 to 3.85% in 2014… Read More »